RECOMBINANT NANOPARTICLE RSV F VACCINE FOR RESPIRATORY SYNCYTIAL VIRUS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

13629107

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVAVAX INC700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Liu, Ye Rockville, US 353 2493
Massare, Michael Rockville, US 8 144
SMITH, Gale Rockville, US 70 738
Wu, Yingyun Rockville, US 17 298

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation